Skip to main content

Table 4 Antibiograms of multi-drug resistanta MRSA from inpatients and outpatientsb

From: Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States

 

Inpatient (n = 6,183)

Outpatient (n = 1,757)

Agents

n

(%) Susceptible

n

(%) Susceptible

Ciprofloxacin

7

(0.1)

5

(0.3)

Erythromycin

20

(0.3)

13

(0.7)

Clindamycin

85

(1.4)

38

(2.2)

Gentamicin

4,971

(80.4)

1,430

(81.4)

Trimethoprim-sulfamethoxazole

5,814

(94.0)

1,657

(94.3)

Linezolid

6,180

(>99.9)

1,757

(100)

Vancomycin

6,183

(100.0)

1,757

(100)

  1. aMultiple-drug resistance: resistance to three or more of the following agents: ciprofloxacin, erythromycin, clindamycin, gentamicin, trimethoprim/sulfamethoxazole, linezolid, and vancomycin
  2. bCumulative data 1998 – 2005 YTD